 Todos Medical Ltd, together with its 3CL protease biology-focused joint venture partner NLC Pharma Ltd, announced that it has received an initial purchase order from its European distribution partner T-Cell Protect Hellas SA for 50,000 bottles of its Tollovid Daily dietary supplement formulated product to be marketed under the T-Cell Protect brand. The company said the initial purchase order is expected to give T-Cell Protect a sufficient amount of product to complete its initial planned roll-out of T-Cell Protect to a subset of its 11,000 store retail distribution network throughout Greece. 